Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
ACR Open Rheumatology|August 23, 2023
RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference MeasuresNicholas Rodwell, Geraldine Hassett, Paul Bird, et al.
Arthritis and Rheumatism|May 18, 2004
Documenting damage progression in a two-year longitudinal study of rheumatoid arthritis patients with established disease (the DAMAGE study cohort): is there an advantage in the use of magnetic resonance imaging as compared with plain radiography?Paul Bird, Bruce Kirkham, Ian Portek, et al.
Clinical Rheumatology|August 9, 2021
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in AustraliaPaul Bird, Geoffrey Littlejohn, Belinda Butcher, et al.
International Journal of Rheumatic Diseases|October 18, 2013
Australian and New Zealand national evidence-based recommendations for the investigation and follow-up of undifferentiated peripheral inflammatory arthritis: an integration of systematic literature research and rheumatological expert opinionClaire Barrett, Paul Bird, Gabor Major, et al.
BMJ Public Health|July 21, 2025
Prevalence of malnutrition among hospital admissions to English NHS hospitals over two economically constrained decades: evidence from routine health dataKatharine Reeves, Samuel I Watson, Hannah Crothers, et al.
RMD Open|March 20, 2019
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinibPaul Bird, Stephen Hall, Peter Nash, et al.
BMJ Quality & Safety|September 5, 2024
Cluster randomised evaluation of a training intervention to increase the use of statistical process control charts for hospitals in England: making data countKelly Ann Schmidtke, Laura Kudrna, Laura Quinn, et al.
Clinical Rheumatology|April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
International Journal of Rheumatology|June 1, 2018
AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid ArthritisPaul Bird, Charles Peterfy, Peter Countryman, et al.
Clinical Rheumatology|March 12, 2020
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in AustraliaPaul Bird, Geoffrey Littlejohn, Belinda Butcher, et al.
Pageof 13